Indication
Nocturnal enuresis
Nocturnal enuresis, commonly referred to as bedwetting, is the involuntary voiding of urine during sleep in individuals who have reached a developmental age where nighttime bladder control is expected, typically defined as five years of age or older. Read more about Nocturnal enuresis
32 drugs 31 manufacturers
Drugs that treat it
Common Nocturnal enuresis therapies.
IMIPRAMINE HCL
IMIPRAMINE HCL
DESMOPRESSIN ACETATE
IMIPRAMINE HCL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonNocturnal enuresis, commonly referred to as bedwetting, is the involuntary voiding of urine during sleep in individuals who have reached a developmental age where nighttime bladder control is expected, typically defined as five years of age or older.
Primarily affecting the pediatric population and the urologic and neurological systems governing micturition, it can present as primary, where dryness has never been sustained, or secondary, where symptoms emerge after a period of continence.
The condition is characterized clinically by repeated nighttime wetting episodes and is driven pathophysiologically by a mismatch between nocturnal bladder capacity and urine production—often secondary to nocturnal polyuria from deficient nighttime antidiuretic hormone secretion, detrusor overactivity, and an inability to arouse from sleep in response to bladder fullness.
- nih.gov
Nocturnal enuresis, commonly referred to as bedwetting, is the involuntary voiding of urine during sleep in individuals who have reached a developmental age where nighttime bladder control is expected, typically defined as five years of age or older
- nih.gov
Nocturnal enuresis, commonly referred to as bedwetting, is the involuntary voiding of urine during sleep in individuals who have reached a developmental age where nighttime bladder control is expected, typically defined as five years of age or older The condition is characterized clinically by repeated nighttime wetting episodes and is driven pathophysiologically by a mismatch between nocturnal bladder capacity and urine production—often secondary to nocturnal polyuria from deficient nighttime a...
- nih.gov
Nocturnal enuresis, commonly referred to as bedwetting, is the involuntary voiding of urine during sleep in individuals who have reached a developmental age where nighttime bladder control is expected, typically defined as five years of age or older Primarily affecting the pediatric population and the urologic and neurological systems governing micturition, it can present as primary, where dryness has never been sustained, or secondary, where symptoms emerge after a period of continence
- nih.gov
The condition is characterized clinically by repeated nighttime wetting episodes and is driven pathophysiologically by a mismatch between nocturnal bladder capacity and urine production—often secondary to nocturnal polyuria from deficient nighttime antidiuretic hormone secretion, detrusor overactivity, and an inability to arouse from sleep in response to bladder fullness
- nih.gov
The condition is characterized clinically by repeated nighttime wetting episodes and is driven pathophysiologically by a mismatch between nocturnal bladder capacity and urine production—often secondary to nocturnal polyuria from deficient nighttime antidiuretic hormone secretion, detrusor overactivity, and an inability to arouse from sleep in response to bladder fullness
Personalize your experience
Follow Nocturnal enuresis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.